EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with...
Main Authors: | Wael H. Roshdy, Helmy A. Rashed, Ahmed Kandeil, Ahmed Mostafa, Yassmin Moatasim, Omnia Kutkat, Noura M. Abo Shama, Mokhtar R. Gomaa, Ibrahim H. El-Sayed, Nancy M. El Guindy, Amal Naguib, Ghazi Kayali, Mohamed A. Ali, Dong-Yan Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673558/?tool=EBI |
Similar Items
-
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2.
by: Wael H Roshdy, et al.
Published: (2020-01-01) -
Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
by: Mokhtar R. Gomaa, et al.
Published: (2020-11-01) -
Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.
by: Ahmed Kandeil, et al.
Published: (2020-01-01) -
Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine
by: Yassmin Moatasim, et al.
Published: (2021-03-01) -
Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Kandeil, et al.
Published: (2021-06-01)